FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2304-2312 June 5, 2003 Number 23 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background The recent development of electrospray tandem mass spectrometry makes it possible to screen newborns for many rare inborn errors of metabolism, but the efficacy and outcomes of screening remain unknown. We examined the effect of the screening of newborns by tandem mass spectrometry on the rates of diagnosis of 31 disorders.

Methods We compared the rates of detection of 31 inborn errors affecting the metabolism of the urea cycle, amino acids, and organic acids and fatty-acid oxidation among 362,000 newborns screened by tandem mass spectrometry over a four-year period (April 1998 through March 2002) with the rates in six preceding four-year birth cohorts in New South Wales and the Australian Capital Territory, Australia, where screening, diagnostic, and clinical services were centralized.

Results The overall prevalence of disorders during the periods when clinical diagnosis was used did not vary between 1982 and 1998. In the cohort screened with tandem mass spectrometry, the prevalence of inborn errors, excluding phenylketonuria, was 15.7 per 100,000 births (95 percent confidence interval, 11.9 to 20.4), as compared with adjusted rates of 8.6 to 9.5 per 100,000 births in the four preceding four-year cohorts. Of the 57 cases diagnosed after the introduction of newborn screening, 15 were diagnosed clinically; 7 of the 15 newborns had a normal result on screening. The rate of detection was increased specifically for medium-chain acyl-coenzyme A dehydrogenase deficiency (P<0.001) and other disorders of fatty-acid oxidation (P=0.007), as compared with the 16-year period before the implementation of neonatal screening for these disorders.

Conclusions More cases of inborn errors of metabolism are diagnosed by screening with tandem mass spectrometry than are diagnosed clinically. It is not yet clear which patients with disorders diagnosed by such screening would have become symptomatic if screening had not been performed.

Source Information

From the New South Wales Newborn Screening Programme (B.W., V.W.); the New South Wales Biochemical Genetics Service (B.W., J.H., K.C.); the Children's Hospital at Westmead (B.W., V.W., J.H., K.C.); and the Discipline of Paediatrics and Child Health, University of Sydney (B.W.) — all in Sydney, Australia.

Address reprint requests to Professor Wilcken at the Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia, or at bridgetw{at}chw.edu.au.

Full Text of this Article

This article has been cited by other articles:

• Bailey, D. B. Jr, Skinner, D., Davis, A. M., Whitmarsh, I., Powell, C. (2008). Ethical, Legal, and Social Concerns About Expanded Newborn Screening: Fragile X Syndrome as a Prototype for Emerging Issues. Pediatrics 121: e693-e704 [Abstract] [Full Text]  
• Bishop Hubbard, H. (2007). Policy Issues Related to Expanded Newborn Screening: A Review of Three Genetic/Metabolic Disorders. Policy Politics Nursing Practice 8: 201-209 [Abstract]  
• Arn, P. H. (2007). Newborn Screening: Current Status. Health Aff (Millwood) 26: 559-566 [Abstract] [Full Text]  
• Sanderson, S, Green, A, Preece, M A, Burton, H (2006). The incidence of inherited metabolic disorders in the West Midlands, UK. Arch. Dis. Child. 91: 896-899 [Abstract] [Full Text]  
• Liebig, M., Schymik, I., Mueller, M., Wendel, U., Mayatepek, E., Ruiter, J., Strauss, A. W., Wanders, R. J.A., Spiekerkoetter, U. (2006). Neonatal Screening for Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: Enzymatic and Molecular Evaluation of Neonates With Elevated C14:1-Carnitine Levels. Pediatrics 118: 1065-1069 [Abstract] [Full Text]  
• van Maldegem, B. T., Duran, M., Wanders, R. J. A., Niezen-Koning, K. E., Hogeveen, M., Ijlst, L., Waterham, H. R., Wijburg, F. A. (2006). Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency.. JAMA 296: 943-952 [Abstract] [Full Text]  
• Tarini, B. A., Christakis, D. A., Welch, H. G. (2006). State Newborn Screening in the Tandem Mass Spectrometry Era: More Tests, More False-Positive Results. Pediatrics 118: 448-456 [Abstract] [Full Text]  
• Botkin, J. R., Clayton, E. W., Fost, N. C., Burke, W., Murray, T. H., Baily, M. A., Wilfond, B., Berg, A., Ross, L. F. (2006). Newborn Screening Technology: Proceed With Caution. Pediatrics 117: 1793-1799 [Full Text]  
• Feuchtbaum, L., Lorey, F., Faulkner, L., Sherwin, J., Currier, R., Bhandal, A., Cunningham, G. (2006). California's Experience Implementing a Pilot Newborn Supplemental Screening Program Using Tandem Mass Spectrometry. Pediatrics 117: S261-S269 [Abstract] [Full Text]  
• Exil, V. J., Gardner, C. D., Rottman, J. N., Sims, H., Bartelds, B., Khuchua, Z., Sindhal, R., Ni, G., Strauss, A. W. (2006). Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. Am. J. Physiol. Heart Circ. Physiol. 290: H1289-H1297 [Abstract] [Full Text]  
• Baumgartner, C., Baumgartner, D. (2006). Biomarker Discovery, Disease Classification, and Similarity Query Processing on High-Throughput MS/MS Data of Inborn Errors of Metabolism. J Biomol Screen 11: 90-99 [Abstract]  
• Browning, M. F., Levy, H. L., Wilkins-Haug, L. E., Larson, C., Shih, V. E. (2006). Fetal Fatty Acid Oxidation Defects and Maternal Liver Disease in Pregnancy. Obstet Gynecol 107: 115-120 [Abstract] [Full Text]  
• La Pean, A., Farrell, M. H. (2005). Initially Misleading Communication of Carrier Results After Newborn Genetic Screening. Pediatrics 116: 1499-1505 [Abstract] [Full Text]  
• Botkin, J. R. (2005). Research for Newborn Screening: Developing a National Framework. Pediatrics 116: 862-871 [Abstract] [Full Text]  
• Acharya, K., Ackerman, P. D., Ross, L. F. (2005). Pediatricians' Attitudes Toward Expanding Newborn Screening. Pediatrics 116: e476-e484 [Abstract] [Full Text]  
• Li, Y., Scott, C. R., Chamoles, N. A., Ghavami, A., Pinto, B. M., Turecek, F., Gelb, M. H. (2004). Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening. Clin. Chem. 50: 1785-1796 [Abstract] [Full Text]  
• Wilcken, B. (2004). Screening of Newborns for Metabolic Disorders With Mass Spectrometry. JAMA 291: 1444-1444 [Full Text]  
• Waisbren, S. (2004). Screening of Newborns for Metabolic Disorders With Mass Spectrometry--Reply. JAMA 291: 1444-1445 [Full Text]  
• Li, Y., Brockmann, K., Turecek, F., Scott, C. R., Gelb, M. H. (2004). Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Krabbe Disease. Clin. Chem. 50: 638-640 [Full Text]  
• Peters, H., Nefedov, M., Sarsero, J., Pitt, J., Fowler, K. J., Gazeas, S., Kahler, S. G., Ioannou, P. A. (2003). A Knock-out Mouse Model for Methylmalonic Aciduria Resulting in Neonatal Lethality. J. Biol. Chem. 278: 52909-52913 [Abstract] [Full Text]  
• Waisbren, S. E., Albers, S., Amato, S., Ampola, M., Brewster, T. G., Demmer, L., Eaton, R. B., Greenstein, R., Korson, M., Larson, C., Marsden, D., Msall, M., Naylor, E. W., Pueschel, S., Seashore, M., Shih, V. E., Levy, H. L. (2003). Effect of Expanded Newborn Screening for Biochemical Genetic Disorders on Child Outcomes and Parental Stress. JAMA 290: 2564-2572 [Abstract] [Full Text]  
• Holtzman, N. A. (2003). Expanding Newborn Screening: How Good Is the Evidence?. JAMA 290: 2606-2608 [Full Text]  
• Chace, D. H., Kalas, T. A., Naylor, E. W. (2003). Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns. Clin. Chem. 49: 1797-1817 [Abstract] [Full Text]  
• Venditti, L. N., Venditti, C. P., Berry, G. T., Kaplan, P. B., Kaye, E. M., Glick, H., Stanley, C. A. (2003). Newborn Screening by Tandem Mass Spectrometry for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cost-Effectiveness Analysis. Pediatrics 112: 1005-1015 [Abstract] [Full Text]